Venous Thromboembolism (VTE)
Venous Thromboembolism (VTE) is categorized as a cardiovascular condition. It is discussed here as an outcome involving risk, including a possible relationship with Vitamin E.
Venous Thromboembolism (VTE) is categorized as a cardiovascular condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
Finnish SaunapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
An observational cohort of 2,242 middle-aged men linked 2-3 sauna sessions per week to lower incident venous thromboembolism risk; sauna was not tested as a treatment.
Open the Finnish Sauna page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesFinnish SaunaCertaintyLowSourceClinical
An observational cohort of 2,242 middle-aged men linked 2-3 sauna sessions per week to lower incident venous thromboembolism risk; sauna was not tested as a treatment.
Who was studied
- People with a condition
Open Finnish SaunaStudy result
Observational association: 2-3 sauna sessions per week linked to lower incident VTE risk in middle-aged men; not tested as treatment.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Venous Thromboembolism (VTE) worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Venous Thromboembolism (VTE) is categorized as a cardiovascular condition. It is discussed here as an outcome involving risk, including a possible relationship with Vitamin E. The reported connection remains uncertain, and more research is needed to confirm it. A clinician can provide context for individual circumstances.
Evidence-backed options
Vitamin E is associated with a possible reduction in the risk of venous thromboembolism in women when used at regular doses. However, the evidence is not sufficient to confirm that this relationship is reliable, and it does not establish which dose, treatment duration, or time to any change in risk should be expected.
The finding applies specifically to women; the health status of the people studied is not specified, so it may not apply equally to every person with venous thromboembolism risk. More research is needed to clarify whether Vitamin E has a meaningful role and to define the circumstances in which any benefit might occur. Decisions about options for venous thromboembolism should be discussed with a clinician.
What to avoid
Cigarette Smoking is flagged for avoidance with Venous Thromboembolism (VTE) because it is contraindicated based on its physiological properties. This indicates that the concern relates to how smoking affects the body in ways considered incompatible with this condition.
The available rationale does not specify a more detailed mechanism, so no narrower explanation is provided here. Anyone with Venous Thromboembolism should discuss the implications of cigarette smoking and any related health decisions with a clinician.